
Context Therapeutics Inc.
CNTXNasdaqCIK 1842952HealthcareFiscal year ends Dec 31
Reports and events: 90 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-10-3109:04 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001842952-23-000082 |
| 2023-08-0916:04 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001842952-23-000078 |
| 2023-08-0708:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001842952-23-000074 |
| 2023-06-2008:35 ET | 8-K | 8.01 Other events | 0001842952-23-000070 |
| 2023-06-0216:05 ET | 8-K | 5.07 Shareholder vote results | 0001842952-23-000065 |
| 2023-05-1016:34 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001842952-23-000054 |
| 2023-04-0616:02 ET | DEF 14A | Proxy statementPeriod 2023-05-31 | 0001842952-23-000048 |
| 2023-03-2217:10 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001842952-23-000041 |
| 2023-03-2217:09 ET | 8-K | 2.02 Results of operations; 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001842952-23-000040 |
| 2023-02-0607:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001842952-23-000015 |
| 2023-01-2716:02 ET | 8-K | 3.01 Delisting notice | 0001842952-23-000010 |
| 2023-01-0407:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001842952-23-000004 |
| 2022-12-0807:32 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001842952-22-000108 |
| 2022-12-0108:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001842952-22-000104 |
| 2022-11-0916:13 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001842952-22-000098 |
| 2022-11-0916:06 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001842952-22-000096 |
| 2022-09-2707:37 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001842952-22-000086 |
| 2022-08-1116:03 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001842952-22-000071 |
| 2022-08-0207:31 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001842952-22-000066 |
| 2022-06-0316:03 ET | 8-K | 5.07 Shareholder vote results | 0001842952-22-000050 |
| 2022-05-1116:18 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001842952-22-000041 |
| 2022-04-0416:10 ET | DEF 14A | Proxy statementPeriod 2022-06-02 | 0001842952-22-000036 |
| 2022-03-2316:17 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001842952-22-000029 |
| 2022-03-2316:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001842952-22-000028 |
| 2022-01-1008:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001842952-22-000009 |
| 2022-01-0516:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001842952-22-000004 |
| 2021-12-1016:46 ET | S-1 | Registration statement | 0001628280-21-024868 |
| 2021-12-0616:47 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001842952-21-000018 |
| 2021-12-0216:06 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001842952-21-000015 |
| 2021-12-0216:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001842952-21-000014 |
| 2021-11-0116:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001842952-21-000005 |
| 2021-10-2216:28 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-305465 |
| 2021-10-1820:20 ET | S-1/A | Registration statement, amended | 0001193125-21-300259 |
| 2021-09-2908:24 ET | S-1/A | Registration statement, amended | 0001193125-21-286130 |
| 2021-09-2416:15 ET | S-1/A | Registration statement, amended | 0001193125-21-282230 |
| 2021-09-1321:24 ET | S-1/A | Registration statement, amended | 0001193125-21-270533 |
| 2021-07-2316:35 ET | S-1/A | Registration statement, amended | 0001193125-21-223067 |
| 2021-07-0221:08 ET | S-1/A | Registration statement, amended | 0001193125-21-206738 |
| 2021-06-1617:13 ET | S-1/A | Registration statement, amended | 0001193125-21-192240 |
| 2021-05-2717:28 ET | S-1 | Registration statement | 0001193125-21-175568 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 11, 2026, 01:22 ET. Listed shows no prices and gives no investment advice.